VERU INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
VERU INC. (VERU) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $530.93 thousand as of 2025-09-30, per its 10-K filed 2025-12-17.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2025-12-17
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $530.93K.
- 2024-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $790.88K.
- 2023-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.12M.
- 2022-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.44M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-09-30 | $530.93K 10-K · filed 2025-12-17 |
| 2024-09-30 | $790.88K 10-K · filed 2024-12-16 |
| 2023-09-30 | $1.12M 10-K/A · filed 2024-04-01 |
| 2022-09-30 | $1.44M 10-K · filed 2022-12-05 |
| 2022-06-30 | $1.54M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.65M 10-Q · filed 2022-05-12 |
| 2021-09-30 | $201.32K 10-K · filed 2021-12-02 |
| 2020-09-30 | $355.65K 10-K · filed 2020-12-10 |
| 2020-06-30 | $328.52K 10-Q · filed 2020-08-13 |
| 2020-03-31 | $362.82K 10-Q · filed 2020-05-13 |
| 2019-12-31 | $418.18K 10-Q · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |